Cohance Lifesciences Limited (NSE: COHANCE) is down 5% intraday at ₹418.9, showing pressure after breakout. Key momentum test at 50-DMA (₹443.8).
Cohance Lifesciences Limited (NSE: COHANCE) stock breaks out, gaining 12% intraday. The stock has cleared its 6M resistance trendline.
Cohance Lifesciences Limited (NSE: COHANCE) stock price rises 5% intraday to ₹428.65, showing a climb in the Healthcare sector.
Cohance Lifesciences Limited (COHANCE) reports FY26 Q4 results, showcasing strategic growth alignment and a transition year outlook for FY27.
